Serum ceruloplasmin as a marker in prostate cancer

Minerva Urologica e Nefrologica

Volumn 59, Issue 4, 2007, Pages 407-411

  Fotiou, K ^a,b   Vaiopoulos, G ^a   Lilakos, K ^a   Giannopoulos, A ^a   Mandalenaki, K ^c   Marinos, G ^a   Koritsiadis, G ^a   Sourdis, J ^d   Konstantinidou, E ^d   Konstantopoulos, K ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b General Hospital of Preveza   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Ceruloplasmin; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

ACID PHOSPHATASE; CERULOPLASMIN; PROSTATE SPECIFIC ANTIGEN;

ACID PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER STAGING; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; CERULOPLASMIN; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 37049028816     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Tanagho AE. Disorders of the bladder, prostate and seminal vesicles. In: Tanago AE, McAninch WJ, editors. Smith's general urology. New York:Mc Graw Hill;2004. p. 576-91.
2. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-16.
3. Armbruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem 1993;39:181-95.
4. Ruckle HC, Klee GG, Oesterling JE. Prostate-specific antigen: concepts for staging prostate cancer and monitoring response to therapy. Mayo Clin Proc 1994;69:69-79.
5. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23.
6. Allhoff EP. Proppe KH, Chapman CM, Lin CW, Prout GR Jr. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer. J Urol 1983;129:315-8.
7. El-Shirbiny AM. Prostatic specific antigen. Adv Clin Chem 1994;31:99-133.
8. Laufer M, Pound CR, Carducci MA, Eisenberger MA. Management of patients with rising prostate-specific antigen after radical prostatectomy. Urology 2000;55:309-15.
9. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995;274:1214-20.
10. Pizzolo G. Savarin T, Molino AM, Ambrosetti A, Todeschini G, Vettore L. The diagnostic value of serum copper levels and other hematochemical parameters in malignancies. Tumori 1987;64:55-61.
11. Agroyannis B, Dalamangas A, Dardouphas K, Fortoynas C, Saloum G, Stringou E et al. Serum transferrin and ceruloplasmin in patients with cancer of the gastrointestinal and other systems. Anticancer Res 1994;14:2201-3.
12. Mortazavi SH, Bani-Hashemi A, Mozafari M, Raffi A. Value of serum copper measurement in lymphomas and several other malignancies. Cancer 1972;29.1193-8.
13. Tessmer CF, Hrgovcic M, Thomas FB, Fuller LM, Castro JR. Serum copper as an index of tumor response to radiotherapy. Radiology 1973;106:635-9.
14. Trautner K, Cooper EH, Haworth S, Ward AM. An evaluation of serum protein profiles in the long-term surveillance of prostatic cancer. Scand J Urol Nephrol 1980;14:143-9.
15. Wilt TJ. Prostate cancer: epidemiology and screening. Rev Urol 2003;5 (Suppl 6):S3-S9.
16. Seto A, Tokuda H, Ito Y. Malignant conversion of Shope papillomas and associated changes of serum ceruloplasmin in domestic rabbits. Proc Soc Exp Biol Med 1978;157:694-6.
17. Ugar-Waron H, Gluckman A, Trainin Z. The source of increased serum ceruloplasmin activity in rabbits bearing the VX-2 carcinoma. J Comp Pathol 1982;92:331-6.
18. Giannoulaki EE, Kalpaxis DL, Tentas C, Fessas P. Lactate dehydrogenase isoenzyme pattern in sera of patients with malignant diseases. Clin Chem 1989;35:396-9.
19. Katopodis N, Hirshaut Y, Geller NL, Stock CC. Lipid-associated sialic acid test for the detection of human cancer. Cancer Res 1982;42:5270-5.
20. Kokoglu E, Sonmez H, Uslu E, Uslu I. Sialic acid levels in various types of cancer. Cancer Biochem Biophys 1992;13:57-64.